demonstrated that CLDN7 is highly expressed in 2774 and HeyA8 human ovarian cancer cells, and inhibiting CLDN7 significantly enhanced the response of 2774 and HeyA8 cells to cisplatin treatment. The gene discussed is CLDN7; the disease is ovarian carcinoma.